Images
Contact
The economic newpaper Expansión reports on the 20th anniversary of the Barcelona Science Park (Parque Científico de Barcelona (PCB). In the article, it mentions that, in addition to hosting biomedical start-ups like Oryzon Genomics, PaloBiofarma, Som Biotech and Kymos Pharma, it is also home to prestigious organisations such as the Institute for Research in Biomedicine (IRB Barcelona), the Instituto de Biología Molecular de Barcelona (IBMB-CSIC), and large companies linked to innovation, such as Esteve and Grupo Ordesa.
"This combination of organisations on the same site makes the PCB unique," explains the director of the PCB, Maria Terrades. "The PCB is not only a key component for the future of the University of Barcelona, but also for the Catalan and Spanish research systems," says the rector of the UB, Joan Elias.
Also in La Vanguardia: El Parque Científico de Barcelona cumple 20 años como polo de innovación científica
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
